Inventor · disambiguated record
Chen-Huan Lin
Also filed as: LIN CHEN · LIN CHEN-HUAN
18 granted patents·9 pending applications·30 citations·filing 2014–2025
90Inventor score
Files withHANGZHOU DAC BIOTECH CO LTD15UNIV CHINA MEDICAL10UNIV MEDICAL HOSPITAL CHINA1UNIV NAT CENTRAL1
Top patents by PatentIndex Score
27 records- 0194US11779663B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2020·Granted Oct 10, 2023·4 cites·10 claims
- 0292US11129910B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2016·Granted Sep 28, 2021·8 cites·33 claims
- 0389US10988733B2Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissueUNIV CHINA MEDICAL·Filed 2020·Granted Apr 27, 2021·2 cites·3 claims
- 0489US10836796B2Derivatives of amanita toxins and their conjugation to a cell binding moleculeHANGZHOU DAC BIOTECH CO LTD·Filed 2016·Granted Nov 17, 2020·11 cites·27 claims
- 0586US12220464B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted Feb 11, 2025·1 cites·21 claims
- 0683US10660918B2Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2017·Granted May 26, 2020·1 cites·6 claims
- 0782US12226437B2Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2022·Granted Feb 18, 2025·0 cites·4 claims
- 0876US10696945B2Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cellsUNIV CHINA MEDICAL·Filed 2017·Granted Jun 30, 2020·1 cites·2 claims
- 0974US12303571B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted May 20, 2025·0 cites·13 claims
- 1074US10646585B2Hydrophilic linkers and ligand-drug conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2018·Granted May 12, 2020·1 cites·14 claims
- 1173US12478695B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted Nov 25, 2025·0 cites·20 claims
- 1272US2025152634A1Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell and method for obtaining multipotent umbilical cord mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2025·Application pending·0 cites
- 1371US11529373B2Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damageUNIV CHINA MEDICAL·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 1469US10456479B2Hydrophilic linkers and ligand-drug conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2015·Granted Oct 29, 2019·1 cites·26 claims
- 1568US2023001001A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1668US2021393790A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1768US2021369855A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1861US2017020924A1Mesenchymal stem cell, method for clonogenic expansion thereof, method for isolating thereof, and use thereofUNIV CHINA MEDICAL·Filed 2015·Application pending·0 cites
- 1957US2020069814A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2017·Application pending·0 cites
- 2055US11458171B2Engineering stem cells for cancer therapyUNIV CHINA MEDICAL·Filed 2019·Granted Oct 4, 2022·0 cites·16 claims
- 2154US11110129B2Method for treating multiple sclerosisUNIV CHINA MEDICAL·Filed 2019·Granted Sep 7, 2021·0 cites·5 claims
- 2249US2023115871A1A conjugate of a cytotoxic agent to a cell binding molecule with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 2346US11098371B2Method for treating urothelial carcinomaUNIV NAT CENTRAL·Filed 2019·Granted Aug 24, 2021·0 cites·6 claims
- 2446US2023010108A1A conjugation linker containing 2,3-diaminosuccinyl groupHANGZHOU DAC BIOTECH CO LTD·Filed 2018·Application pending·0 cites
- 2545US2023241241A1Conjugates of a cell-binding molecule with camptothecin analogsHANGZHOU DAC BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 2640US9718835B220(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agentUNIV MEDICAL HOSPITAL CHINA·Filed 2014·Granted Aug 1, 2017·0 cites·26 claims
- 2736US10035791B2Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereofUNIV CHINA MEDICAL·Filed 2016·Granted Jul 31, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Chen-Huan Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →